Esco Aster’s contract testing services are built upon well-established
protocols for culturing various adherent cells, encompassing
mesenchymal stromal cells, pluripotent stem cells, fibroblasts, keratinocytes, and their
derivatives like extracellular particles and exosomes. We are adept at
handling genetically modified cell therapies
, notably
CAR-T/Immune cells, ensuring comprehensive support across advanced
cellular research and development.
Morever, we have demonstrated our expertise in large-scale production techniques with our ability to
culture pluripotent stem cells (PSCs) in aggregates using a 500-liter single-use bioreactor for
cultivated meat applications. Our capability with collaborators in creating CHO/HEK293 Cell Research Banks further bolsters the production of biopharmaceuticals (e.g. erythropoietin, checkpoint inhibitors, bispecific antibodies) and can be used for contract services.